The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2022 | The importance of easing the burden of referrals for CAR-T therapy in aggressive B-cell lymphomas
Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, shares some insights into the challenges of administering CAR-T cell therapy to patients with aggressive B-cell lymphomas, and further explains how the burden of referrals for CAR-T can be eased, highlighting the importance of communication between physicians and cell therapy centers. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
